ANTI-HEPATITIS-C VIRUS-ANTIBODIES - PREVA LENCE IN PATIENTS UNDER HEMODIALYSIS, FAMILY RELATED AND, NEPHROLOGY STAFF

Citation
C. Jimenez et al., ANTI-HEPATITIS-C VIRUS-ANTIBODIES - PREVA LENCE IN PATIENTS UNDER HEMODIALYSIS, FAMILY RELATED AND, NEPHROLOGY STAFF, Nefrologia, 13(5), 1993, pp. 430-434
Citations number
NO
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
02116995
Volume
13
Issue
5
Year of publication
1993
Pages
430 - 434
Database
ISI
SICI code
0211-6995(1993)13:5<430:AV-PLI>2.0.ZU;2-7
Abstract
Hepatitis C is the most frequent type of non-A, non-B hepatitis in pat ients on hemodialysis (HD). We have studied during two years the preva lence of plasma HCV antibodies in unselected patients on HD and the an ti-HCV antibody evolution through the ELISA-I, ELISA-II and RIBA. We h ave determinated the anti-HCV among relatives of dialyzed patients and staff members of dialysis unit. The prevalence of HCV antibodies was 58.7% in hemodialysis patients. We found 24% false-negatives with ELIS A. Two patients (6.3%) become anti-HCV positives during these two year s. Time of dialysis and previous blood transfussion seem to increase t he prevalence of HCV antibodies. Renal transplant is not a risk factor to be carrier of the HCV antibodies. 3.07% of the relatives and 9.62% of the spouses were anti-HCV positive. The health-care staff studied was anti-HCV negative. These data show that intrafamilial spread and s exual transmission could be possible. The usual hygienic recomendation s in hemodyalisis units are enough to avoid the viral transmission.